Dr Pierpaolo Pattacini
The interim analysis of data from the Italian Reggio Emilia Tomosynthesis (RETomo) trial has just been published [1]. This randomized trial involving nearly 30000 women was designed to compare the use of digital breast tomosynthesis (DBT) combined with standard digital mammography (DM) versus the use of DM alone for the detection of breast cancer.